Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in diabetic hemodialysis patients
IRCT20130812014333N217Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of empagliflozin in diabetes mellitus (DM) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Blood sugar, Diuresis and 4 more. Started Jun 2024; status: completed.
02
Drugs
empagliflozin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on IRCT20130812014333N217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N217.